All posts by nedhamson

Activist, writer, researcher, addicted to sharing information and facts.

Perfume de escritor

Before laptop computers and smart phones, I used to keep “notes” and “write” text for both fiction and non-fiction in my head as dreams or mind films while traveling. I’d run and rerun them until I got back home and could then transcribe into my desktop computer.

Santiago Galicia Rojon Serrallonga

SANTIAGO GALICIA ROJON SERRALLONGA

Derechos reservados conforme a la ley/ Copyright

Alguien dijo, una vez, que huelo a papel, a libro, y a tinta, a bolígrafo, a páginas impresas, mezcla que forma, inevitablemente, el encanto de una fragancia, especial que no tiene precio porque se trata, simplemente, de perfume de escritor. Y es que, a pesar de que conozco y manejo la tecnología de la hora contemporánea, soy un artista de las letras, muy romántico, proclive a escribir mis textos en un cuaderno o en una libreta, antes de transcribirlos en la computadora y publicarlos. En ocasiones, por la dinámica cotidiana, me resulta imposible tomar el bolígrafo y escribir sobre una hoja de papel; entonces recurro, directamente, a los equipos modernos y me entrego al arte. He escrito fragmentos de mis obras en servilletas, pedazos de cartón, trozos de papel, boletos y comprobantes de pago de las tiendas, porque la…

View original post 175 more words

Conspiracists have published a ‘frank admission’ by Brett Sutton about boosters. Here’s what he really said – ABC News

By some estimates, they initially offered 85-95 per cent protection against the original Wuhan strain, and upwards of 85 per cent against the Alpha variant.

ATAGI has since written that a booster dose “augmented protection against infection” from the more severe Delta variant and provided “a substantial increase in the protective effectiveness against symptomatic disease and infection” from the more infectious Omicron.

Professor van Zemm explained that the evidence showed vaccines did protect against infection, “especially in the first month after vaccination”.

However, he said, that protection was never 100 per cent in the first place, which meant that while vaccination clearly made a person’s risk of infection “much lower”, it would not protect everybody all of the time.

Source: Conspiracists have published a ‘frank admission’ by Brett Sutton about boosters. Here’s what he really said – ABC News

Long Covid keeping 2-4 million Americans out of workforce, report says | Coronavirus | The Guardian

About 16 million working-age Americans have long-term Covid and 2-4 million are out of work because of its ill effects, according to a new report from the Brookings Institution.

Employers have complained of labor shortages throughout the pandemic, and the analysis of data from the US Census Bureau’s Household Pulse Survey, which collects data from Americans through a survey on education, employment, health and housing, suggests one possible reason for the lack of workers.

The report found that about 16 million Americans between 18 and 65 have long Covid. Of these people, who are considered of working age, they estimate that 2 to 4 million are out of work because of their symptoms.

Source: Long Covid keeping 2-4 million Americans out of workforce, report says | Coronavirus | The Guardian

Paxlovid, molnupiravir benefit older COVID-19 patients, 2 studies show | CIDRAP

A pair of new studies describes the clinical benefits of two oral antiviral drugs in COVID-19 patients amid the Omicron period, one from Israel suggesting that nirmatrelvir-ritonavir (Paxlovid) reduced rates of hospitalization and death in people 65 years or older, and research from Hong Kong demonstrating that Paxlovid and molnupiravir lowered rates of death, disease progression, and the need for supplemental oxygen in older hospitalized patients.

In the United States, the Food and Drug Administration (FDA) granted emergency use authorization for oral Paxlovid and molnupiravir for the treatment of patients with mild or moderate COVID-19 at high risk for severe illness within 5 days of symptom onset, regardless of vaccination status.

 

Source: Paxlovid, molnupiravir benefit older COVID-19 patients, 2 studies show | CIDRAP